Ruibai Luo1, Pei-Wen Chen1,2, Jean-Cheng Kuo3,4, Lisa Jenkins5, Xiaoying Jian1, Clare M Waterman3, Paul A Randazzo1. 1. Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD, 20892, USA. 2. Department of Biology, Williams College, Williamstown, MA, 01267, USA. 3. Cell Biology and Physiology Center, National Heart, Lung, and Blood Institutes, Bethesda, MD, 20892, USA. 4. Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, 112, Taiwan. 5. Laboratory of Cell Biology, National Cancer Institute, Bethesda, MD, 20892, USA.
Abstract
BACKGROUND INFORMATION: ARAP2, an Arf GTPase-activating protein (Arf GAP) that binds to adaptor protein with PH domain, PTB domain and leucine zipper motifs 1 (APPL1), regulates focal adhesions (FAs). APPL1 affects FA dynamics by regulating Akt. Here, we tested the hypothesis that ARAP2 affects FAs in part by regulating Akt through APPL1. RESULTS: We found that ARAP2 controlled FA dynamics dependent on its enzymatic Arf GAP activity. In some cells, ARAP2 also regulated phosphoAkt (pAkt) levels. However, ARAP2 control of FAs did not require Akt and conversely, the effects on pAkt were independent of FAs. Reducing ARAP2 expression reduced the size and number of FAs in U118, HeLa and MDA-MB-231 cells. Decreasing ARAP2 expression increased pAkt in U118 cells and HeLa cells and overexpressing ARAP2 decreased pAkt in U118 cells; in contrast, ARAP2 had no effect on pAkt in MDA-MB-231 cells. An Akt inhibitor did not block the effect of reduced ARAP2 on FAs in U118. Furthermore, the effect of ARAP2 on Akt did not require Arf GAP activity, which is necessary for effects on FAs and integrin traffic. Altering FAs by other means did not induce the same changes in pAkt as those seen by reducing ARAP2 in U118 cells. In addition, we discovered that ARAP2 and APPL1 had co-ordinated effects on pAkt in U118 cells. Reduced APPL1 expression, as for ARAP2, increased pAkt in U118 and the effect of reduced APPL1 expression was reversed by overexpressing ARAP2. Conversely, the effect of reduced ARAP2 expression was reversed by overexpressing APPL1. ARAP2 is an Arf GAP that has previously been reported to affect FAs by regulating Arf6 and integrin trafficking and to bind to the adaptor proteins APPL1. Here, we report that ARAP2 suppresses pAkt levels in cells co-ordinately with APPL1 and independently of GAP activity and its effect on the dynamic behaviour of FAs. CONCLUSIONS: We conclude that ARAP2 affects Akt signalling in some cells by a mechanism independent of FAs or membrane traffic. SIGNIFICANCE: Our results highlight an Arf GAP-independent function of ARAP2 in regulating Akt activity and distinguish the effect of ARAP2 on Akt from that on FAs and integrin trafficking, which requires regulation of Arf6.
BACKGROUND INFORMATION: ARAP2, an Arf GTPase-activating protein (Arf GAP) that binds to adaptor protein with PH domain, PTB domain and leucine zipper motifs 1 (APPL1), regulates focal adhesions (FAs). APPL1affects FA dynamics by regulating Akt. Here, we tested the hypothesis that ARAP2affects FAs in part by regulating Akt through APPL1. RESULTS: We found that ARAP2controlled FA dynamics dependent on its enzymatic Arf GAP activity. In some cells, ARAP2 also regulated phosphoAkt (pAkt) levels. However, ARAP2control of FAs did not require Akt and conversely, the effects on pAkt were independent of FAs. Reducing ARAP2expression reduced the size and number of FAs in U118, HeLa and MDA-MB-231 cells. Decreasing ARAP2expression increased pAkt in U118 cells and HeLa cells and overexpressing ARAP2 decreased pAkt in U118 cells; in contrast, ARAP2 had no effect on pAkt in MDA-MB-231 cells. An Akt inhibitor did not block the effect of reduced ARAP2 on FAs in U118. Furthermore, the effect of ARAP2 on Akt did not require Arf GAP activity, which is necessary for effects on FAs and integrin traffic. Altering FAs by other means did not induce the same changes in pAkt as those seen by reducing ARAP2 in U118 cells. In addition, we discovered that ARAP2 and APPL1 had co-ordinated effects on pAkt in U118 cells. Reduced APPL1expression, as for ARAP2, increased pAkt in U118 and the effect of reduced APPL1expression was reversed by overexpressing ARAP2. Conversely, the effect of reduced ARAP2expression was reversed by overexpressing APPL1. ARAP2 is an Arf GAP that has previously been reported to affect FAs by regulating Arf6 and integrin trafficking and to bind to the adaptor proteins APPL1. Here, we report that ARAP2 suppresses pAkt levels in cells co-ordinately with APPL1 and independently of GAP activity and its effect on the dynamic behaviour of FAs. CONCLUSIONS: We conclude that ARAP2affects Akt signalling in some cells by a mechanism independent of FAs or membrane traffic. SIGNIFICANCE: Our results highlight an Arf GAP-independent function of ARAP2 in regulating Akt activity and distinguish the effect of ARAP2 on Akt from that on FAs and integrin trafficking, which requires regulation of Arf6.
Authors: Tanmay P Lele; Jay Pendse; Sanjay Kumar; Matthew Salanga; John Karavitis; Donald E Ingber Journal: J Cell Physiol Date: 2006-04 Impact factor: 6.384
Authors: Roberto Zoncu; Rushika M Perera; Daniel M Balkin; Michelle Pirruccello; Derek Toomre; Pietro De Camilli Journal: Cell Date: 2009-03-20 Impact factor: 41.582
Authors: Elizabeth Sztul; Pei-Wen Chen; James E Casanova; Jacqueline Cherfils; Joel B Dacks; David G Lambright; Fang-Jen S Lee; Paul A Randazzo; Lorraine C Santy; Annette Schürmann; Ilka Wilhelmi; Marielle E Yohe; Richard A Kahn Journal: Mol Biol Cell Date: 2019-05-15 Impact factor: 4.138
Authors: Salvatore G Caradonna; Tie-Yuan Zhang; Nicholas O'Toole; Mo-Jun Shen; Huzefa Khalil; Nathan R Einhorn; Xianglan Wen; Carine Parent; Francis S Lee; Huda Akil; Michael J Meaney; Bruce S McEwen; Jordan Marrocco Journal: Neuropsychopharmacology Date: 2021-11-30 Impact factor: 8.294